Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials

Chimeric Antigen Receptor T-cell (CAR-T) therapy uses genetically engineered T-cells with specific binding sites. This therapy allows for tumor specificity and durable treatment responses for patients with hematological malignancies. In this review, we study the risk of venous thromboembolism (VTE)...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Akshit Chitkara, Sushanth Sreenivasan, Yue Yin, Maitreyee Rai, Santhosh Sadashiv
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	MDPI AG 2024-07-01
Sraith:	Current Oncology
Ábhair:	Chimeric Antigen Receptor T-cell (CAR-T) venous thromboembolism meta-analysis hematological malignancies mantle cell lymphoma B-cell lymphoma
Rochtain ar líne:	https://www.mdpi.com/1718-7729/31/8/323
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!